L
Luis M. Ruilope
Researcher at European University of Madrid
Publications - 891
Citations - 109166
Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Obesity and hypertension in Latin America: Current perspectives.
TL;DR: The current status for the prevalence and consequences of obesity and hypertension in Latin America is summarized, with the aim of initiating a call to action to all stakeholders for greater implementation of primary prevention strategies, particularly in the young.
Journal ArticleDOI
Comparison of Agents That Affect Aldosterone Action
TL;DR: The first aldosterone blocker, spironolactone, initially was used as a diuretic but was accompanied by a significant amount of side effects that necessitated the withdrawal of the drug in a relevant number of patients as discussed by the authors.
Journal ArticleDOI
Hypertension in Latin America: Current perspectives on trends and characteristics.
Luis M. Ruilope,A.C.P. Chagas,A.A. Brandão,R. Gómez-Berroterán,J.J.A. Alcalá,J.V. Paris,J.J.O. Cerda +6 more
TL;DR: The epidemiological and management trends and patterns in hypertension that may be specific or more common to Latin-American populations - what the authors term 'Latin American characteristics' of hypertension - are discussed via a review of the recent literature.
Journal ArticleDOI
Effects of long-term treatment with indomethacin on renal function.
Luis M. Ruilope,R. Garcia Robles,C. Paya,Jose M. Alcazar,E Miravalles,J Sancho-Rof,Jose L. Rodicio,Franklyn G. Knox,Juan C. Romero +8 more
TL;DR: Prolonged treatment with indomethacin induced chronic hyporeninism and hypoaldosteronism, and some of the symptoms of a syndrome of hypoprostaglandinism, such as decreased plasma renin activity, plasma aldosterone, and urinary prostaglandsin E2 in association with increases in plasma potassium levels and diastolic pressure.
Journal ArticleDOI
Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME.
Rosaura Maeso,Josefa Navarro-Cid,Elena Rodrigo,Luis M. Ruilope,Victoria Cachofeiro,Vicente Lahera +5 more
TL;DR: The administration of L-NAME in Sprague-Dawley rats increased the production of endothelium-derived hyperpolarizing factor as a compensatory mechanism to maintain acetylcholine-induced relaxation.